<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00265564</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 04-175</org_study_id>
    <nct_id>NCT00265564</nct_id>
  </id_info>
  <brief_title>SUPER Study (Substance Use and PTSD Treatment Effectiveness Research Study)</brief_title>
  <official_title>Effectiveness of Screening and Treatment for PTSD in SUD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study proposes a prospective program of research that will identify feasible and&#xD;
      inexpensive methods to detect and treat comorbid PTSD among VA SUD patients, thereby&#xD;
      improving substance abuse treatment outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: This study proposes a prospective program of research that will identify feasible&#xD;
      and inexpensive methods to detect and treat comorbid PTSD among VA SUD patients, thereby&#xD;
      improving substance abuse treatment outcomes.&#xD;
&#xD;
      Objective(s): Our objectives are to test the effectiveness of substituting 2 hours/week of&#xD;
      Seeking Safety-based groups for standard substance use focused groups for male patients&#xD;
      attending outpatient substance use disorder treatment who meet clinical criteria for PTSD.&#xD;
      Primary outcomes measures will assess substance use disorder severity and secondary outcome&#xD;
      measures will assess mental health and substance use related problems plus treatment&#xD;
      satisfaction. We hypothesize that enhanced SUD treatment that incorporates &quot;Seeking Safety&quot;&#xD;
      will improve SUD treatment outcomes for PTSD-SUD patients as compared to outcomes for&#xD;
      PTSD-SUD patients receiving treatment as usual. Additionally, we examine two hypothesized&#xD;
      models via which &quot;Seeking Safety&quot; may effect substance use outcomes. We examine whether 1)&#xD;
      reductions in PTSD symptomatology and 2) improvements in coping strategies used in response&#xD;
      to PTSD symptoms (reductions in using to cope and other avoidance coping strategies)&#xD;
      partially mediate the effect of treatment on substance use outcomes.&#xD;
&#xD;
      Methods: This is a randomized clinical trial of 210 male veterans with PTSD and substance use&#xD;
      disorders attending outpatient substance use disorder treatment at the VA Oakland mental&#xD;
      health center. Patients will be randomized to 3 months of outpatient substance abuse&#xD;
      treatment including either 2 hours/week of &quot;Seeking Safety&quot; or standard addiction focused&#xD;
      group therapy. Data will be collected in patient interviews at treatment entry and at 3, 6&#xD;
      and 12 months after treatment initiation and by medical record review. Substance use, PTSD&#xD;
      symptomatology, mental health, social functioning, legal problems, use of coping techniques,&#xD;
      and treatment satisfaction outcomes will be assessed at treatment entry and 3, 6 and 12&#xD;
      months later using well-validated survey instruments. Primary and secondary treatment&#xD;
      outcomes of patients in &quot;Seeking Safety&quot; versus treatment as usual will be compared by&#xD;
      repeated measures ANCOVA. We will test the mediational hypotheses according to the 4-step&#xD;
      method described by Baron and Kenny (1986).&#xD;
&#xD;
      Status: Project began in January, 2006; Recruitment, treatment and assessment is complete and&#xD;
      primary trial finds are published. Secondary analysis is ongoing.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2006</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of Alcohol Use (ASI Alcohol Composite Scores)</measure>
    <time_frame>Administered at baseline and 3 months, 6 months and 12 months post baseline.</time_frame>
    <description>Alcohol and drug use composite scores were separately analyzed. The ASI alcohol composite score measures the severity of substance use and amount of use in the past 30 days and consequences of use. Scored as values between 0 and 1 with higher values indicating more severe substance use (i.e. lower values indicate a better outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ASI Drug Composite Score</measure>
    <time_frame>1 year</time_frame>
    <description>Addiction Severity Index (ASI) drug composite scores measure past 30 days substance use (McLellan et al., 1992). The ASI assesses lifetime and current use of all major classes of drugs of abuse, history of substance-related problems, and history of SUD treatment. Scored as values between 0 and 1 with higher values indicating more severe substance use (i.e. lower values indicate a better outcome).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PTSD Symptoms (IES Total Score)</measure>
    <time_frame>Administered at 3 months, 6 months and 12 months post enrollment</time_frame>
    <description>Composite measures of PTSD symptoms. Items are rated on a 5-point scale ranging from 0 (&quot;not at all&quot;) to 4 (&quot;extremely&quot;). Total score ranging from 0 (not at all) to 88 (extremely)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">117</enrollment>
  <condition>Substance Use Disorders</condition>
  <condition>Posttraumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>Seeking Safety</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Seeking Safety is a manualized, empirically supported, cognitive behavioral therapy that treats substance use disorders and comorbid PTSD. Participants assigned to the Seeking Safety arm attend two one hour sessions of group therapy for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual Care Condition. Patients randomized to usual care will receive standard outpatient SUD treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Modified Seeking Safety integrated into std outpatient SUD care</intervention_name>
    <description>The Seeking Safety treatment involves two (one hour) sessions of manualized group therapy for 12 weeks.</description>
    <arm_group_label>Seeking Safety</arm_group_label>
    <other_name>Seeking Safety</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard outpatient SUD care</intervention_name>
    <description>Patients assigned to standard care meet twice weekly in &quot;Recovery 1&quot; groups, which focuses on building abstinence.</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. veteran status and VA healthcare eligibility,&#xD;
&#xD;
          2. a diagnosis of any alcohol or drug use disorder,&#xD;
&#xD;
          3. having completed an intake for outpatient SUD treatment at the VA Oakland outpatient&#xD;
             mental health clinic, and&#xD;
&#xD;
          4. meeting criteria for a PTSD diagnosis based on a preliminary screen with the PC-PTSD&#xD;
             and subsequent full clinical evaluation using the CAPS&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. current participation in any day or inpatient mental health treatment,&#xD;
&#xD;
          2. any contraindications communicated by that patient's primary clinician,&#xD;
&#xD;
          3. acute psychosis, mania, dementia, or suicidal intent&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jodie A. Trafton, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Palo Alto Health Care System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304-1290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Weaver CM, Trafton JA, Walser RD, Kimerling RE. Pilot test of seeking safety treatment with male veterans. Psychiatr Serv. 2007 Jul;58(7):1012-3.</citation>
    <PMID>17602023</PMID>
  </results_reference>
  <results_reference>
    <citation>Boden MT, Kimerling R, Jacobs-Lentz J, Bowman D, Weaver C, Carney D, Walser R, Trafton JA. Seeking Safety treatment for male veterans with a substance use disorder and post-traumatic stress disorder symptomatology. Addiction. 2012 Mar;107(3):578-86. doi: 10.1111/j.1360-0443.2011.03658.x.</citation>
    <PMID>21923756</PMID>
  </results_reference>
  <results_reference>
    <citation>Oliva EM, Harris AH, Trafton JA, Gordon AJ. Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors. Drug Alcohol Depend. 2012 May 1;122(3):241-6. doi: 10.1016/j.drugalcdep.2011.10.004. Epub 2011 Nov 23.</citation>
    <PMID>22115887</PMID>
  </results_reference>
  <results_reference>
    <citation>Midboe AM, Cucciare MA, Trafton JA, Ketroser N, Chardos JF. Implementing motivational interviewing in primary care: the role of provider characteristics. Transl Behav Med. 2011 Dec;1(4):588-94. doi: 10.1007/s13142-011-0080-9.</citation>
    <PMID>24073081</PMID>
  </results_reference>
  <results_reference>
    <citation>Harris AH, Oliva E, Bowe T, Humphreys KN, Kivlahan DR, Trafton JA. Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence. Psychiatr Serv. 2012 Jul;63(7):679-85. doi: 10.1176/appi.ps.201000553.</citation>
    <PMID>22549276</PMID>
  </results_reference>
  <results_reference>
    <citation>Tyler Boden M, Kimerling R, Kulkarni M, Bonn-Miller MO, Weaver C, Trafton J. Coping among military veterans with PTSD in substance use disorder treatment. J Subst Abuse Treat. 2014 Aug;47(2):160-7. doi: 10.1016/j.jsat.2014.03.006. Epub 2014 Apr 13.</citation>
    <PMID>24854218</PMID>
  </results_reference>
  <results_reference>
    <citation>Zimmerman L, Lounsbury DW, Rosen CS, Kimerling R, Trafton JA, Lindley SE. Participatory System Dynamics Modeling: Increasing Stakeholder Engagement and Precision to Improve Implementation Planning in Systems. Adm Policy Ment Health. 2016 Nov;43(6):834-849. Erratum in: Adm Policy Ment Health. 2021 Mar;48(2):377.</citation>
    <PMID>27480546</PMID>
  </results_reference>
  <results_reference>
    <citation>Kearney LK, Smith C, Kivlahan DR, Gresen RC, Moran E, Schohn M, Trafton J, Zeiss AM. Mental health productivity monitoring in the Veterans Health Administration: Challenges and lessons learned. Psychol Serv. 2018 Nov;15(4):486-495. doi: 10.1037/ser0000173. Epub 2017 Jul 17.</citation>
    <PMID>28714721</PMID>
  </results_reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>December 13, 2005</study_first_submitted>
  <study_first_submitted_qc>December 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2005</study_first_posted>
  <results_first_submitted>April 23, 2015</results_first_submitted>
  <results_first_submitted_qc>August 19, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 7, 2020</results_first_posted>
  <last_update_submitted>August 19, 2020</last_update_submitted>
  <last_update_submitted_qc>August 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>outcomes assessment</keyword>
  <keyword>substance use disorders</keyword>
  <keyword>stress disorders, post-traumatic</keyword>
  <keyword>screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Seeking Safety</title>
          <description>Seeking Safety is a manualized, empirically supported, cognitive behavioral therapy that treats substance use disorders and comorbid PTSD. Participants assigned to the Seeking Safety arm attend two one hour sessions of group therapy for 12 weeks.&#xD;
Modified Seeking Safety integrated into std outpatient SUD care: The Seeking Safety treatment involves two (one hour) sessions of manualized group therapy for 12 weeks.</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>Usual Care Condition. Patients randomized to usual care will receive standard outpatient SUD treatment.&#xD;
Standard outpatient SUD care: Patients assigned to standard care meet twice weekly in &quot;Recovery 1&quot; groups, which focuses on building abstinence.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="58"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>met exclusion criteria</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Seeking Safety</title>
          <description>Seeking Safety is a manualized, empirically supported, cognitive behavioral therapy that treats substance use disorders and comorbid PTSD. Participants assigned to the Seeking Safety arm attend two one hour sessions of group therapy for 12 weeks.&#xD;
Modified Seeking Safety integrated into std outpatient SUD care: The Seeking Safety treatment involves two (one hour) sessions of manualized group therapy for 12 weeks.</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>Usual Care Condition. Patients randomized to usual care will receive standard outpatient SUD treatment.&#xD;
Standard outpatient SUD care: Patients assigned to standard care meet twice weekly in &quot;Recovery 1&quot; groups, which focuses on building abstinence.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="49"/>
            <count group_id="B2" value="49"/>
            <count group_id="B3" value="98"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.30" spread="9.38"/>
                    <measurement group_id="B2" value="53.01" spread="9.96"/>
                    <measurement group_id="B3" value="54.13" spread="9.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Severity of Alcohol Use (ASI Alcohol Composite Scores)</title>
        <description>Alcohol and drug use composite scores were separately analyzed. The ASI alcohol composite score measures the severity of substance use and amount of use in the past 30 days and consequences of use. Scored as values between 0 and 1 with higher values indicating more severe substance use (i.e. lower values indicate a better outcome).</description>
        <time_frame>Administered at baseline and 3 months, 6 months and 12 months post baseline.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Seeking Safety</title>
            <description>Seeking Safety is a manualized, empirically supported, cognitive behavioral therapy that treats substance use disorders and comorbid PTSD. Participants assigned to the Seeking Safety arm attend two one hour sessions of group therapy for 12 weeks.&#xD;
Modified Seeking Safety integrated into std outpatient SUD care: The Seeking Safety treatment involves two (one hour) sessions of manualized group therapy for 12 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care Condition. Patients randomized to usual care will receive standard outpatient SUD treatment.&#xD;
Standard outpatient SUD care: Patients assigned to standard care meet twice weekly in &quot;Recovery 1&quot; groups, which focuses on building abstinence.</description>
          </group>
        </group_list>
        <measure>
          <title>Severity of Alcohol Use (ASI Alcohol Composite Scores)</title>
          <description>Alcohol and drug use composite scores were separately analyzed. The ASI alcohol composite score measures the severity of substance use and amount of use in the past 30 days and consequences of use. Scored as values between 0 and 1 with higher values indicating more severe substance use (i.e. lower values indicate a better outcome).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".259" spread=".264"/>
                    <measurement group_id="O2" value=".225" spread=".237"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".169" spread=".191"/>
                    <measurement group_id="O2" value=".152" spread=".129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".138" spread=".173"/>
                    <measurement group_id="O2" value=".141" spread=".146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".149" spread=".168"/>
                    <measurement group_id="O2" value=".134" spread=".137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We investigated treatment condition differences in change of drug and alcohol use over four time-points using generalized linear mixed modeling analyses. A trajectory for each participant was modeled yielding estimates of baseline scores (intercept), slope, and error. Four between-person parameters were estimated: average baseline score for all participants, average slope over time in TAU condition, effect of being in SS on average intercept, effect of being in SS on average slope.</groups_desc>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>&gt; .05</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>ASI Drug Composite Score</title>
        <description>Addiction Severity Index (ASI) drug composite scores measure past 30 days substance use (McLellan et al., 1992). The ASI assesses lifetime and current use of all major classes of drugs of abuse, history of substance-related problems, and history of SUD treatment. Scored as values between 0 and 1 with higher values indicating more severe substance use (i.e. lower values indicate a better outcome).</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Seeking Safety</title>
            <description>Seeking Safety is a manualized, empirically supported, cognitive behavioral therapy that treats substance use disorders and comorbid PTSD. Participants assigned to the Seeking Safety arm attend two one hour sessions of group therapy for 12 weeks.&#xD;
Modified Seeking Safety integrated into std outpatient SUD care: The Seeking Safety treatment involves two (one hour) sessions of manualized group therapy for 12 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care Condition. Patients randomized to usual care will receive standard outpatient SUD treatment.&#xD;
Standard outpatient SUD care: Patients assigned to standard care meet twice weekly in &quot;Recovery 1&quot; groups, which focuses on building abstinence.</description>
          </group>
        </group_list>
        <measure>
          <title>ASI Drug Composite Score</title>
          <description>Addiction Severity Index (ASI) drug composite scores measure past 30 days substance use (McLellan et al., 1992). The ASI assesses lifetime and current use of all major classes of drugs of abuse, history of substance-related problems, and history of SUD treatment. Scored as values between 0 and 1 with higher values indicating more severe substance use (i.e. lower values indicate a better outcome).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".089" spread=".080"/>
                    <measurement group_id="O2" value=".106" spread=".084"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".057" spread=".062"/>
                    <measurement group_id="O2" value=".095" spread=".091"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".051" spread=".060"/>
                    <measurement group_id="O2" value=".088" spread=".091"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".046" spread=".053"/>
                    <measurement group_id="O2" value=".066" spread=".062"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;.05</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PTSD Symptoms (IES Total Score)</title>
        <description>Composite measures of PTSD symptoms. Items are rated on a 5-point scale ranging from 0 (&quot;not at all&quot;) to 4 (&quot;extremely&quot;). Total score ranging from 0 (not at all) to 88 (extremely)</description>
        <time_frame>Administered at 3 months, 6 months and 12 months post enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Seeking Safety</title>
            <description>Seeking Safety is a manualized, empirically supported, cognitive behavioral therapy that treats substance use disorders and comorbid PTSD. Participants assigned to the Seeking Safety arm attend two one hour sessions of group therapy for 12 weeks.&#xD;
Modified Seeking Safety integrated into std outpatient SUD care: The Seeking Safety treatment involves two (one hour) sessions of manualized group therapy for 12 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care Condition. Patients randomized to usual care will receive standard outpatient SUD treatment.&#xD;
Standard outpatient SUD care: Patients assigned to standard care meet twice weekly in &quot;Recovery 1&quot; groups, which focuses on building abstinence.</description>
          </group>
        </group_list>
        <measure>
          <title>PTSD Symptoms (IES Total Score)</title>
          <description>Composite measures of PTSD symptoms. Items are rated on a 5-point scale ranging from 0 (&quot;not at all&quot;) to 4 (&quot;extremely&quot;). Total score ranging from 0 (not at all) to 88 (extremely)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.76" spread="19.49"/>
                    <measurement group_id="O2" value="47.66" spread="16.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.80" spread="20.86"/>
                    <measurement group_id="O2" value="42.40" spread="21.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.90" spread="16.72"/>
                    <measurement group_id="O2" value="36.47" spread="16.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.26" spread="20.44"/>
                    <measurement group_id="O2" value="34.07" spread="17.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Generalized linear mixed modeling analysis</groups_desc>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>&gt;.05</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Seeking Safety</title>
          <description>Seeking Safety is a manualized, empirically supported, cognitive behavioral therapy that treats substance use disorders and comorbid PTSD. Participants assigned to the Seeking Safety arm attend two one hour sessions of group therapy for 12 weeks.&#xD;
Modified Seeking Safety integrated into std outpatient SUD care: The Seeking Safety treatment involves two (one hour) sessions of manualized group therapy for 12 weeks.</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>Usual Care Condition. Patients randomized to usual care will receive standard outpatient SUD treatment.&#xD;
Standard outpatient SUD care: Patients assigned to standard care meet twice weekly in &quot;Recovery 1&quot; groups, which focuses on building abstinence.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jodie Trafton, Director Program Evaluation and Resource Center</name_or_title>
      <organization>Office of Mental Health Operation, Veterans Health Administration</organization>
      <phone>650-493-5000 ext 22474</phone>
      <email>Jodie.Trafton@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

